The Neuropsychology of Psychopharmacology

Double click on above image to view full picture

Zoom Out
Zoom In

The Neuropsychology of Psychopharmacology

SKU# 9780826107169

Editors:

  • Chad A. Noggle PhD, ABN
  • Raymond S. Dean PhD, ABPP, ABN, ABPdN
  • Simon Crowe PhD
  • Stephen Soltys M.D.
  • Stephen Robinson M.D.
$125.00

Buy From:

Amazon

Description 

The use of pharmacological interventions to treat the symptoms of psychological disorders is readily becoming the first-line option for clinicians and their clients. Although most neurological and psychiatric professionals are well versed in medicinal agents, many remain uninformed about current pharmacologic practices that may have positive or negative neuropsychological impact. This text serves as an up-to-date reference for clinicians and researchers, covering current practices and advances in pharmacological interventions for psychiatric and neurological presentations and the pharmacologic mechanisms that influence the actions of the central nervous system and behavioral outcomes.

Key Topics:

  • Foundational principles and concepts relevant to pharmacology, including: agent selection, addressing symptoms, physiological factors, and treatment guidelines
  • Pharmacological principles of pharmacokinetics and drug uptake
  • Comparison of positive and negative outcomes of drug interactions
  • Specific practices in pharmacology, including comparative efficacy of agents as well as differential selection based on symptom constellation

Product Details 

  • Publication Date November 15, 2017
  • Page Count 504
  • Product Form Hardback
  • ISBN 13 9780826107169
  • EISBN 9780826107176

Online Supplements 

Want to learn more about The Neuropsychology of Psychopharmacology and the Contemporary Neuropsychology Series? Watch our interviews with editor Chad Noggle:

Table of Contents 

Section I: Foundational Principles

Chapter 1: Foundations of Pharmacology
Chapter 2: Pharmacokinetics
Chapter 3: Neuropshysiology & Pharmacology

Section II. Types & Classes of Agents

Chapter 4: Antidepressants: MAOIs & Tricyclics
Chapter 5: Antidepressants: SSRIs & SNRIs
Chapter 6: Anxiolytics
Chapter 7: Psychostimulants
Chapter 8: Typical Antipsychotics
Chapter 9: Atypical Antipsychotics
Chapter 10: Acetylcholinestrase Inhibitors & Agonists
Chapter 11: Dopmaninergic Antagonists
Chapter1 2: Anticonvulsants
Chapter1 3: Analgesics

Section III. Pharmacological Interventions for Presentations & Special Considerations

Chapter 14: Pharmacology of ADHD & Externalizing Disorders
Chapter 15: Pharmacology of Pervasive Developmental Disorders
Chapter 16: Pharmacology of Mood Disorders
Chapter 17: Pharmacology of Anxiety Disorders
Chapter 18: Pharmacology of Psychotic Disorders
Chapter 19: Pharmacology of Somatoform Disorders
Chapter 20: Pharmacology of Dementing Disorders
Chapter 21: Pharmacology of Movement Disorders
Chapter 22: Pharmacology of Seizures & Epilepsy
Chapter 23: Pharmacology of Demyelinating Diseases
Chapter 24: Pharmacology of Genetic & Chromosomal Disorders
Chapter 25: Pharmacology of Chronic Medical Conditions
Chapter 26: Pharmacology in Traumatic Brain Injury
Chapter 27: Pharmacology in Rehabilitation
Chapter 28: Assessing Neurological Impact of Pharmacology
Chapter 29: Improving Treatment Adherence